Skip to main content
Log in

TB screening + treatment of young asylum seekers arriving in Germany may be cost effective

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Marx FM, et al. Targeting screening and treatment for latent tuberculosis infection towards asylum seekers from high-incidence countries - a model-based cost-effectiveness analysis. BMC Public Health : 1 Dec 2021. Available from: URL: https://doi.org/10.1186/s12889-021-12142-4

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

TB screening + treatment of young asylum seekers arriving in Germany may be cost effective. PharmacoEcon Outcomes News 893, 31 (2021). https://doi.org/10.1007/s40274-021-08262-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-08262-7

Navigation